ABL Bio, Dementia Theme Rises 15.47% Up

On the 18th, the dementia theme showed strength by rising 3.03% compared to the previous day, while ABL Bio, which is attracting attention as a related stock, surged by 15.47% compared to the previous day.

[Graph] Major Stocks' Price Changes in the Dementia Theme

According to provisional data compiled at 11:56, foreigners purchased 102,500 shares and institutions bought 26,000 shares of ABL Bio, resulting in simultaneous large net purchases by both foreigners and institutions.

[Table] Net Trading Volume by Foreigners and Institutions (Unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, ABL Bio's quant financial score was 5.73 points, ranking 34th in the dementia-related theme. This can be interpreted as ABL Bio having relatively low investment attractiveness from a financial perspective. On the other hand, Koryo Pharmaceutical ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Scores within the Theme

※ The quant financial score is the result of the robo algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.